Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
28
datasets available to search
ShareScore release 0.7.1
Dataset results
28 results for “national responsibility”
Carbon exchange responses of rehydrated and incubated biological soil crust samples from White Sands National Park in 2020-2022
This dataset contains photosynthetic light response data from biological soil crusts collected from a gypsum sand sheet at White Sands National Park, NM, USA in three different seasons. This study aims to 1) assess the carbon fixation capacity of biocrust types; 2) assess biocrust carbon fixation response under varying incubation times; 3) and understand variability in carbon fixation response in different seasons. Sample collection occurred in July 2020 (summer), September 2021 (fall), and March 2022 (winter). The biocrust types of interest were light cyanobacterial, dark cyanobacterial, Peltula lichen, Clavascidium lichen, and moss crusts. Samples were collected with the intention of taking carbon fixation measurements after different incubation periods (30 min, 2 hr, 6 hr, 12hr, or 24 hr in 2020, and 30 min, 2 hr, 6 hr, 12hr, 24 hr, or 36 hr in 2021 and 2022). For each condition (biocrust type and incubation time) there were five replicates in 2020 (total n=125) and ten replicates in 2021 and 2022 (total n=300). After collection, the intact samples were re-wetted and subjected to their respective incubation period and measured for photosynthetic response. The resulting light response curves and photosynthetic information was be used for comparing biocrust type, incubation time response differences, and seasonal variation to understand variability of biocrust carbon flux response at a single site. This data set includes the light response curve values and photosynthetic data calculated from these curves and raw LICOR output files compiled into 3 spreadsheet files. The included 2020 data is also associated with the White Sands National Park data from Jornada Study 549. This dataset accompanies the in-press article by Hoellrich et al. (2023) cited below, and the study is now complete. Hoellrich, Mikaela R., Darren K. James, David Bustos, Anthony Darrouzet-Nardi, Louis S. Santiago, and Nicole Pietrasiak. "Biocrust carbon exchange varies with crust type and time on Ch
Arbuscular mycorrhizal fungal response to fire and urbanization in the Great Smoky Mountains National Park
Wildfires are increasing in frequency and intensity as drier and warmer climates increase plant detrital fuel loads. At the same time, increases in urbanization position 9% of fire-prone land within the US at the wildland-urban interface. While rarely studied, the compounded effects of urbanization and wildfires may have unknown synergistically negative effects on ecosystems. Previous studies at the wildland-urban interface often focus on aboveground plant communities, but belowground ecosystems may also be affected by this double disturbance. In particular, it is unclear how much fire and urbanization independently or interactively affect nutritional symbioses such as those between arbuscular mycorrhizal (AM) fungi and the majority of terrestrial plants. In November 2016, extreme drought conditions and long-term fire suppression combined to create a wildfire within the Great Smoky Mountains National Park (GSMNP) and the neighboring exurban city of Gatlinburg, TN. To understand how the double disturbance of urbanization and fire affected AM fungal communities, we collected fine roots from the five dominant understory species in September 2018 at each of 18 sites spanning three burn severities in both exurban and natural sites. Despite large variation in burn severity, plant species identity had the largest influence on AM fungi. AM fungal colonization, richness, and composition all varied most among plant species. Fire and urbanization did influence some AM fungal metrics; colonization was lower in burned sites and composition was more variable among exurban locations. There were no interactions among burn severity and urbanization on AM fungi. Our results point to the large influence of plant species identity structuring this obligate nutritional symbiosis regardless of disturbance regime. Therefore, the majority of AM fungal taxa may be buffered from fire-induced ecosystem changes if plant community composition largely remains intact, plant species life history tr
National Open Access Monitor Survey: Organisational Identity: Responses Dataset
<p>This dataset contains the response data from the 'National Open Access Monitor Survey: Organisational Identity which was carried out between 9th October and 9th November 2023 under the National Open Access Monitor Project: <a href="https://zenodo.org/doi/10.5281/zenodo.8420404">https://zenodo.org/doi/10.5281/zenodo.8420404</a></p><p><strong>This survey was run to:</strong></p><ul><li>compile a complete list of Irish research performing organisations (RPO) and research funding organisations (RFO) to be represented by the National Open Access Monitor.</li><li>ensure each organisation/entity is categorised correctly as an RPO or an RFO (or both), as applicable.</li><li>identify if an organisation/entity is publicly funded.</li><li>identify formally affiliated organisations/entities where <strong>all </strong>research outputs of one organisation/entity should also be included in the research outputs of another organisation/entity.</li><li>capture the persistent identifiers for RPOs, RFOs and publishers, to enable identification of relevant research outputs for the National Open Access Monitor.</li></ul><p><strong>To note: </strong></p><ul><li>Respondents' email addresses have been redacted.</li><li>Responses have been pseudonymised to the level of stakeholder-group e.g. Contributor A, Research Funding Organisation A, where requested by the participant in the participant consent form: <a href="https://doi.org/10.5281/zenodo.7589770">https://doi.org/10.5281/zenodo.7589770</a>.</li><li>Respondents were notified of the limits of pseudonymisation for this survey. Due to the nature and purpose of this survey on Organisational Identity, the identity of the organisation/entity could not be pseudonymised. Participants were advised only to participate if they were happy to do so under these conditions.</li><li>Survey responses were deleted by request of certain respondents. These responses are not included in these files.</li><li>Survey respondents were enabled to update their submissions. These changes are captured in the <i>NationalOpenAccessMonitorSurvey.OrganisationalIdentity.MasterChangeFile.</i></li></ul><p><strong>There are four files within in this dataset:</strong></p><p>- <i>Results.NationalOpenAccessMonitorSurvey.OrganisationalIdentity.README - </i>this PDF details the changes made to the raw data, as specified in the bullet points above and a description of the files within the dataset.</p><p>- <i>Results.NationalOpenAccessMonitorSurvey.OrganisationalIdentity.Pseudonymised.101123</i> - this is the original raw data, in csv format, as downloaded from the Online Surveys platform and subsequently pseudonymised and redacted.</p><p>- <i>NationalOpenAccessMonitorSurvey.OrganisationalIdentity.MasterChangeFile.101123 </i>- this is a change file, in csv format, which documents the changes which participants requested to be made to their submissions after they were received.</p><p>- R<i>esults.NationalOpenAccessMonitorSurvey.OrganisationalIdentity.Pseudonymised.Updated.101123 - </i>this is the original raw data, pseudonymised and redacted, with the requested changes implemented.</p><p><strong>Notes for data use:</strong></p><ul><li>The "affiliated organisations/entities" section of the survey was insufficiently described in the survey text. One-to-one follow-up and support was provided to clarify to respondents that questions 12 and 13 of the survey intended to identify where <strong>all </strong>research outputs of one organisation/entity should appear on that organisation's/entities' own RPO or RFO dashboard within the National Open Access Monitor, and <strong>also </strong>on the dashboard of another organisation/entity. </li><li>Survey respondents were notified in the introduction section to the "affiliated organisations/entities" section that "<strong>only where all entities agree there is a formal relationship in place</strong> that should be reflected in the Monitor will the link be implemented". Therefore, for the National Open Access Monitor project, only where both parties have asserted that <strong>all </strong>research outputs of one organisation/entity should also appear on the dashboard of another organisation/entity, will it be considered validated and implemented. </li><li>The geographic scope of the National Open Access Monitor Project is the Republic of Ireland. Where respondent's RPO or RFO organisations/entities are based outside the Republic of Ireland, or where respondents stated affiliations with overseas organisations/entities, they will not be actioned or implemented. To note: the survey invited responses from international <i>publishers</i> to enable filtering functionality by publisher within the National Open Access Monitor, these responses are <i>not </i>out of scope. </li></ul><p>-----------------------</p><p>The context for the survey is detailed in the National Open Access Monitor Project Plan: <a href="https://doi.org/10.5281/zenodo.7331431">https://doi.org/10.5281/zenodo.7331431</a>, the National Open Access Monitor Advisory Group Meeting Minutes, 18th September 2023: <a href="https://zenodo.org/doi/10.5281/zenodo.8405472">https://zenodo.org/doi/10.5281/zenodo.8405472</a> and the Developing the National Open Access Monitor, Ireland: Stakeholder Webinar, 22nd September 2023: <a href="https://zenodo.org/doi/10.5281/zenodo.8370578">https://zenodo.org/doi/10.5281/zenodo.8370578.</a></p><p>This project is managed by <a href="http://www.irel.ie/">IReL </a>and has received funding from Ireland's National Open Research Forum under the NORF Open Research Fund. <a href="https://norf.ie/funding/">https://norf.ie/funding/ </a><a href="https://norf.ie/orf-projects-announcement/">https://norf.ie/orf-projects-announcement/</a></p>
National Open Access Monitor, Draft Report: Stakeholder Feedback: Response Dataset
<p>This dataset contains the response data from the 'National Open Access Monitor, Draft Report: Stakeholder Feedback' Form which was open from 16th to 30th November 2023 under the National Open Access Monitor Project. A PDF reference copy of the Feedback Form is available here: <a href="https://zenodo.org/doi/10.5281/zenodo.10141988">https://zenodo.org/doi/10.5281/zenodo.10141988</a></p><p>The purpose of the form was to capture stakeholder feedback on the National Open Access Monitor, Ireland Draft Report, for actioning by OpenAIRE in the final National Open Access Monitor Report to be delivered in January 2024. The draft is an interim report, and includes reference to the initial feedback from IReL and the National Open Access Monitor Project Advisory Group.</p><p><strong>To note: </strong></p><ul><li>Responses have been pseudonymised to the level of stakeholder-group e.g. Contributor I, Research Performing Organisation I, where requested by the participant in the participant consent form: <a href="https://doi.org/10.5281/zenodo.7589770">https://doi.org/10.5281/zenodo.7589770</a></li><li>This is the original raw data file, in csv format, as downloaded from the Online Surveys platform and subsequently pseudonymised.</li></ul><p>-----------------------</p><p>The context for the feedback form is detailed in the National Open Access Monitor Project Plan: <a href="https://doi.org/10.5281/zenodo.7331431">https://doi.org/10.5281/zenodo.7331431</a>, the National Open Access Monitor Advisory Group Meeting Minutes, 27th October 2023: <a href="https://zenodo.org/doi/10.5281/zenodo.10105023 ">https://zenodo.org/doi/10.5281/zenodo.10105023 </a>and the OpenAIRE National Open Access Monitor Ireland, Draft Report: <a href="https://zenodo.org/doi/10.5281/zenodo.10136295">https://zenodo.org/doi/10.5281/zenodo.10136295</a></p><p>This project is managed by <a href="http://www.irel.ie/">IReL </a>and has received funding from Ireland's National Open Research Forum under the NORF Open Research Fund. <a href="https://norf.ie/funding/">https://norf.ie/funding/ </a><a href="https://norf.ie/orf-projects-announcement/">https://norf.ie/orf-projects-announcement/</a></p>
Supplementary material 1 from: Schmeller D, Maier A, Evans D, Henle K (2012) National responsibilities for conserving habitats – a freely scalable method. Nature Conservation 3: 21-44. https://doi.org/10.3897/natureconservation.3.3710
The annex does provide a more detailed comparison of the different biogeographic maps. It further gives a list of all forest habitats given in the EU Habitats Direction
Figure 4 in Diatom responses to river water quality in the Kruger National Park, South Africa
Figure 4. The relationship between SPI and two physicochemical water quality parameters. Open symbols represent rivers with large catchments outside the KNP. Closed represent rivers with relatively small parts of their catchments outside the KNP. In both cases, the dark- er the symbol, the larger the catchment.
Figure 3 in Diatom responses to river water quality in the Kruger National Park, South Africa
Figure 3. Two-dimension MDS plot of diatom community composition in 1983 and 2015 at different sites along the Olifants (OM and OC), Letaba (LC and LK) and Sabie rivers (SL and SB). Note that all sites' diatom composition shifted significantly from 1983 to 2015 irrespective of whether the index values changed or not (see Table 4). Sample site abbreviations also in Table 4.
Figure 2 in Diatom responses to river water quality in the Kruger National Park, South Africa
Figure 2. Long-term changes in two selected river chemical parameters in the Olifants, Letaba and Sabie rivers between 1983 and 2015. The closed symbols represent data extracted from the Department of Water Affairs and Sanitation. Open symbols represent the values recorded at sites within the three focal rivers during the present study in 2015.
Figure 1. A in Diatom responses to river water quality in the Kruger National Park, South Africa
Figure 1. A map of the Kruger National Park, showing the location of the study area and diatom sampling sites.
National Open Access Monitor Survey: Defining Requirements: Responses Dataset
<p>This dataset contains the response data from the ‘National Open Access Monitor Survey: Defining Requirements’ which was carried out between February 2-28th 2023 under the National Open Access Monitor Project: <a href="https://doi.org/10.5281/zenodo.7588787">https://doi.org/10.5281/zenodo.7588787</a></p> <p>To note: </p> <ul> <li>Email addresses have been redacted. </li> <li>Responses have been pseudonymised to the level of stakeholder-group e.g. Contributor 1, Research Funding Organisation #, where requested by the participant in the participant consent form: <a href="https://doi.org/10.5281/zenodo.7589770">https://doi.org/10.5281/zenodo.7589770</a>. </li> <li>Detail within responses by individuals who requested pseudonymisation, which might identify the individual or the organisation has been removed and marked "[redacted]".</li> <li>Responses by individuals who did not provide a signed consent form in advance of contributing to the survey were deleted immediately on receipt, as advised in the survey text: <a href="https://doi.org/10.5281/zenodo.7588787">https://doi.org/10.5281/zenodo.7588787</a>. Such responses are not included in these files.</li> </ul> <p>There are five files within in this dataset:</p> <p>- <em>Results.NationalOpenAccessMonitorSurvey.DefiningRequirements.README - </em>this PDF details the changes made to the raw data, as specified in the bullet points above and a description of the files within the dataset.</p> <p>- <em>Results.NationalOpenAccessMonitorSurvey.DefiningRequirements.Pseudonymised.100323</em> - this is the original raw data, in csv format, as downloaded from the Online Surveys platform and subsequently pseudonymised and redacted.</p> <p>- <em>NationalOpenAccessMonitor.DefiningRequirements.Contributor3Government1.270223 - </em>this PDF file contains a single pseudonymised stakeholder response to the survey, obtained by the Project Manager by email and not through the Online Surveys platform.</p> <p>- <em>NationalOpenAccessMonitorSurvey.MasterChangeFile.080323 </em>- this is a change file, in csv format, which documents the changes which participants requested to be made to their submissions after they were received and the survey was closed.</p> <p>- <em>Results.NationalOpenAccessMonitorSurvey.DefiningRequirements.Pseudonymised.Updated.100323 - </em>this is the original raw data, pseudonymised and redacted, with the requested changes implemented. This is the file on which analysis was carried out for the purposes of the <a href="http://doi.org/10.5281/zenodo.7822367">survey outcome report</a> and the resulting National Open Access Monitor tender documents. </p> <p>------------------------</p> <p>The context for the survey files is detailed in the National Open Access Monitor Project Plan: <a href="https://doi.org/10.5281/zenodo.7331431">https://doi.org/10.5281/zenodo.7331431</a></p> <p>This project is managed by <a href="http://www.irel.ie/">IReL </a>and has received funding from Ireland’s National Open Research Forum under the NORF Open Research Fund. <a href="https://norf.ie/funding/">https://norf.ie/funding/</a> <a href="https://norf.ie/orf-projects-announcement/">https://norf.ie/orf-projects-announcement/</a></p>
Twenty years of Salix height in response to experimental manipulation of browsing and water table, northern range of Yellowstone National Park
<p>This respository contains multiple datasets collected during a 20 year investigation of the responses of willow (<em>Salix </em>spp.) communities in Yellowstone National Park after the restoration of large carnivores. The study sought to understand whether the restoration of wolves to the food web cause a change in the state of willow communities that occured while wolves were absent. Each dataset has a corresonding file of metadata. </p>
Twenty years of Salix height in response to experimental manipulation of browsing and water table, northern range of Yellowstone National Park
Open the record for dataset details and reuse information.
Post-Fire Response of Perennial Grass Communities at McKenzie Flats, Sevilleta National Wildlife Refuge, New Mexico (1998 and 2001)
We evaluated the effects of a lightning-initiated fire on responses of vegetation communities. Following a fire in July 1998, 25 experimental plots were established on the eastern edge of MacKenzie Flats at the Sevilleta National Wildlife Refuge. Ten of these plots were located in a Bouteloua gracilis (blue grama)- dominated site, while 15 were established in another area dominated by Bouteloua eriopoda (black grama). We evaluated basal and aerial cover of all plant species at the community level using a vertical line point intercept method along transects within plots. Sampling was conducted immediately after the fire during the last week of July 1998, and again in September and October of 2001.
Post-Fire Responses of Perennial Grass Populations at McKenzie Flats, Sevilleta National WIldlife Refuge, New Mexico (1998 and 2001)
We evaluated the effects of a lightning-initiated fire on resprouting responses of perennial grasses at the population level. Following a fire in July 1998, 25 experimental plots were established on the eastern edge of MacKenzie Flats at the Sevilleta National Wildlife Refuge. Ten of these plots were located in a Bouteloua gracilis (blue grama)-dominated site, while 15 were established in an area dominated by Bouteloua eriopoda (black grama). We evaluated basal cover of perennial grasses in systematically positioned quadrats (subsamples) within plots immediately after the fire (last week of July 1998), and in September-October 2001.
Vehicle-to-grid Response on 13 February 2024 in Australian National Electricity Market
<p>This data captures the response of 16 Nissan LEAF electric vehicles to a frequency contingency in the Australian National Electricity Market on the 13th of February 2024, which led to widespread blackouts in Melbourne. The data comes from the bidirectional Wallbox Quasar chargers, as well as six high speed power meters located at the grid connection of each of the properties in which the vehicles were charging.</p>
D1.4 - Consolidated OA data set for responsible research practices and trust in science: POIESIS National and Regional Database
<p>Deliverable 1.4 of the POIESIS project is a consolidated open access data set for responsible research practices and trust in science. D1.4 consists of two databases: the POIESIS National Database and the POEISIS Regional Database. The method and rationale behind the construction of all indicators in both databases are laid out in Work Package 1’s previous deliverable, D1.3 (Bauer et al., 2024). The two database are accompanied by a Guidance Sheet which provides details and relevant notes regarding the structure of the two databases. </p> <p> </p>
Localizing Commitments, Challenges, and Insights on the Road to Immunization Agenda 2030: Responses from 6,185 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle, 7 March - 20 June 2022)
<p># Localizing Commitments, Challenges, and Insights on the Road to Immunization Agenda 2030: Responses from 6,185 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle, 7 March - 20 June 2022)</p> <p>## Abstract<br> This data set contains survey responses from over 6,000 national and subnational immunization staff who applied to participate in a 2022 Full Learning Cycle (FLC) learning programme of The Geneva Learning Foundation (TGLF), intended to contribute to the Movement for Immunization Agenda 2030. The 95-item questionnaire collected information on respondents' commitment to the movement's principles, demographics, work challenges, motivation and learning culture, and the impact of COVID-19 on routine immunization. The purpose was to understand applicants' priority challenges and readiness to engage in peer learning to advance country and global immunization goals. Questions addressed consent, identity confirmation, COVID-19 vaccination status, employer, role, system level, past participation in the sponsoring organization's programs, work and wellbeing, difficulties with COVID-19 vaccination, outbreak response, gender equity, and reaching zero-dose children. Applicants identified one priority challenge in their work that they would seek to address through the program. This data set offers insights into frontline perspectives on strengthening immunization programs. Secondary analysess were performed in 2022 and 2023 to illuminate human resource issues, gender barriers, pandemic recovery, and peer learning for change.</p> <p>## Research Audience</p> <p>Education and global health researchers with interest in human resources for health (HRH) and the characteristics, priority challenges, and experiences of national and sub-national immunization staff participating in the Movement for Immunization Agenda (IA) 2030.</p> <p>## Credits</p> <p>### Author</p> <p>The Geneva Learning Foundation (TGLF)<br> 18 Avenue Louis Casaï <br> CH1209 Geneva, Switzerland<br> research@learning.foundation</p> <p>### Principal Investigator and Corresponding Author<br> Reda Sadki, TGLF<br> reda@learning.foundation</p> <p>### Project Partners<br> - Biostat Global Consulting (BGC)<br> - Bridges to Development<br> - Centre for Change & Complexity in Learning (C3L)</p> <p>### Partners' Roles and Responsibilities<br> - Design: TGLF<br> - Implementation (sample collection): TGLF<br> - Processing: TGLF, C3L<br> - Anonymization: BGC<br> - Data cleaning: Bridges to Development<br> - Submission: TGLF<br> - Maintenance of learning analytics database where data are stored: C3L</p> <p>### Funding<br> Wellcome Trust, Bill & Melinda Gates Foundation (BMGF)</p> <p>## Recommended Citation<br> The Geneva Learning Foundation, 2023. Full Learning Cycle (2022) Application for national and sub-national immunization staff to identify challenges and join the Movement for Immunization Agenda (IA 2030) (Version 1.0) [Data Set]. The Geneval Learning Foundation. [DOI:https://doi.org/10.5281/zenodo.8199552](https://zenodo.org/record/8199552)</p> <p>## File List<br> IA2030_EN_FLC_2022_Application_Survey.README.md (this document)</p> <p>20220211.IA2030-EN Movement application-FINAL.docx: List of questions included in the questionnaire. (Note: skip patterns are not shown.)</p> <p>IA2030_EN_Application_Survey_Dataset.xlsx: English version of anonymized Application Survey Dataset. Version 1: Geneva Learning Foundation, 11 August 2023. (6,669 observations; 58 variables)</p> <p>## Related Data Sets<br> This is a subset of data collected by The Geneva Learning Foundation (TGLF) during the first IA2030 Full Learning Cycle (FLC). The complete IA2030 Application Survey data set is more comprehensive, and includes information such as respondents' gender, employer, professional role, country, and health system level, as well as responses to open-text questions. </p> <p>Researchers who would like to analyze the full set of unredacted responses are invited to contact the Geneva Learning Foundation to inquire about a Data Sharing Agreement that would stipulate conditions of access (insights@learning.foundation).</p> <p>The Geneva Learning Foundation, 2023. Value Creation Stories (VCS) weekly feedback survey, 2022 Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) (Version 1.0). [Data Set]. The Geneva Learning Foundation. DOI: https://doi.org/10.5281/zenodo.7763922 </p> <p>Additional data sets for the first Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) are available from TGLF's Insights Unit (<insights@learning.foundation>).</p> <p>## Survey Purpose</p> <p>The Immunization Agenda 2030, the global immunization strategy for 2021-2030, set ambitious targets for global immunization coverage and other key indicators (World Health Organization [WHO], 2023a).</p> <p>In response to the WHO Director-General's call for a social movement to ensure immunization remains a priority for global and regional health agendas and promote broad societal support for immunization (WHO, 2023b), TGLF, working with its global community of over 35,000 alumni, developed a learning programme intended to contribute to a “Movement for Immunization Agenda 2030 (IA2030)”.</p> <p>In addition to participating in structured peer learning activities, applicants made a pledge to work towards IA2030 and their country's goals, adhere to the IA2030 core principles, and to provide support to their peers making similar commitments.</p> <p>The purpose of the IA2030 Application Survey was to collect demographic and organizational information from immunization workers who work at the national or sub-national level interested in applying for the 2022 Learning Cycle and for membership in the Movement for IA2030.</p> <p>## Survey Questionnaire<br> The survey questionnaire consisted of both quantitative (Likert) and qualitative (open-text) responses to 95 questions documenting respondents' commitment to joining the Movement for IA2030 and adhering to relevant principles, demographic characteristics, information about work history and role, work and well-being, learning culture and performance, COVID-19 recovery efforts through vaccination campaigns and routine immunization (including outreach), priority work-related challenges, and most important reason for wanting to join the Movement for IA2030.</p> <p>Survey content was informed by TGLF's six years of experience working with thousands of immunization workers from over 90 countries.</p> <p>The survey was administered in English and French. While most of questions were required, several items, including questions about work and well-being and COVID-19 vaccination status, were optional.</p> <p>### Question Scaling and Response Options<br> Most questions were asked with a 'select one response' instruction, but several encouraged the respondent to 'select all that apply'.<br> - AP_CAR_20 Which of these job categories apply to you?<br> - AP_ENV_55 Where you work, what strategies have been put in place to reach under immunized or zero-dose children?<br> - AP_CHA_63 Is your challenge related to any of these?<br> - AP_ENV_78 What actions are being taken at your level of the health system to strengthen RI or PHC that specifically takes advantage of some aspect of COVID-19 vaccine introduction?<br> - AP_ENV_87 Select all activities used for catch-up.<br> - AP_ENV_91 What were the disruptions related to?</p> <p>Each person's several responses are stored in a single text variable and separated by commas. Some data management will be necessary to divide these strings of text into individual variables to represent each response option.</p> <p>## Overview of questionnaire for respondents<br> The following information was shared with all applicants to provide an overview of the questions and their rationale.</p> <p>First, we ask you for:<br> - Consent to share your data, to confirm your supervisor’s support, and to make commitments to follow country and WHO guidelines on COVID-19 and immunization<br> - Your legal name and birthdate to confirm your identity for certification.<br> - Your WhatsApp number to connect you with other participants in the Movement.<br> - Your organization, role, and health system level, and if you are a TGLF alum.<br> - We ask you about your work and well-being: Before we ask you about the challenges you face, we ask about your work and well-being, especially your motivation and how learning is being supported where you work.<br> - We ask about the challenges you face: In 2020, global immunization coverage levels for infants dropped back to 2009 levels. It is like we lost 11 years of hard work. So we ask you about the challenges you face: COVID-19 vaccination, epidemic outbreaks (measles, yellow fever, etc.), gender barriers, and zero-dose children.<br> - We ask you to pick the challenge that you will work on in the Movement: Then we ask you to identify your most difficult and important challenge. This is the one that you will focus on in the Movement. (You can always change later.)<br> - Are you truly committed to learning with colleagues from all over the world? Because the Movement is about learning, sharing experience, and collaborating with others, we ask you to confirm to what extent this is what you want to do.<br> - We ask you to share your successes, ideas, and lessons learned: Because we know that you have many strengths, we ask you if you want to share a success story, and idea, or a lesson learned with colleagues.<br> - We ask you if you want to help build and shape the Movement for IA2030: We ask you if you want to join the Organizing Committee to help build the Movement for Immunization Agenda 2030.<br> - Global partners request your help: Finally, we ask you to answer questions that IA2030 global partners are specifically interested in, about the effect of COVID-19 on routine immunization, catch-up activities, and your own COVID-19 vaccination. (You can choose to skip these questions.)</p> <p>### Specific questions that respondents were encouraged to reflect upon before writing out their answers<br> - Tell us more about your work and well-being. What are the worst and best parts of your job? Where do you find the motivation to continue your work? What helps you feel involved in your work? How has the COVID-19 pandemic changed how you feel about your work? What makes you lose or gain your motivation? <br> - Tell us more about the effect of the introduction of the COVID-19 vaccine for routine immunization (RI) and primary health care (PHC) services in the area where you work. Explain what has happened. What measures, if any, have been taken to mitigate disruptions or potential disruptions to health workers involvement in routine immunization due to COVID-19 vaccination activities where you work?<br> - Do you have a story about gender barriers to immunization that you would like to share?<br> - Tell us more about what you are doing to reach zero-dose children and missed communities. <br> - Tell us more about how we can better support you. What are the barriers for you to tackle the challenge you face? For your challenge, what kind of support would be most helpful to you? Why? Tell us more about your motivation to join the Movement for Immunization Agenda 2030. What do you hope to gain? What do you want to contribute? How will participating in this Movement help you improve your work?<br> - Do you have something that you want to share with colleagues? What you share does not need to be a “big” idea. We are interested in what you are doing that helps you to continue or improve your immunization work, even in a small way.</p> <p>## Ethical Considerations<br> Prior to fielding of the survey, the survey instrument and protocol were subjected to ethical and legal review by TGLF.</p> <p>Prior to beginning the survey, prospective respondents reviewed a User Agreement and a summary of TGLF's Privacy Policy (https://www.learning.foundation/pages/privacy), which provides information about the personal information the Foundation collects; the ways in which the Foundation uses personal information; and TGLF's procedures for protecting the loss, misuse or alteration of personal information.</p> <p>Participants who chose to respond to the items relevant to work and well-being and organizational culture were promised that their responses would be strictly confidential and that only anonymous, aggregated data would be shared with others.</p> <p>## Recruitment Process and Description of the Sample<br> Members of TGLF's immunization learning community were invited to participate in the survey by email and were encouraged to invite relevant colleagues (immunization workers who work at either the national or sub-national level) to participate by sharing the invitation.</p> <p>Respondents accessed the survey via the Internet by clicking on the survey link contained in the email.</p> <p>Inclusion criteria for participation in the survey included being an immunization worker who works at the national or sub-national level.</p> <p>Only individuals who indicated their direct supervisor at work agreed with their participation and who completed the consent form were permitted to complete a survey.</p> <p>## Survey Design and Administration<br> This one-time Internet-based survey was administered as part of the launch of the IA2030 Movement.</p> <p>The survey was available from February 22, 2022 - June 17, 2022.</p> <p>Respondents did not receive any incentives for completing the survey.</p> <p>The survey was hosted on the Typeform server. The survey itself and all information collected for the survey was secured with multiple levels of encryption and access controls to guarantee participant confidentiality, per Typeform policy (https://www.typeform.com/help/a/security-at-typeform-360029259552/?tid=200afff9-65b2-46e2-9553-0063f2c808b6).</p> <p>## Data Processing and Cleaning<br> Duplicate surveys were identified using respondents' email addresses and were removed from the data file.</p> <p>When a duplicate survey was submitted, only the most recent survey data were retained.</p> <p>## Data Privacy and Anonymization<br> The data file shared on this site is intentionally incomplete. Columns holding personally identifying information (e.g., email address, gender, country) have been deleted.</p> <p>Out of an abundance of caution, columns that could potentially hold personally identifying information (i.e., responses to open-text questions) have been deleted.</p> <p>In accordance with the privacy policy noted in the questionnaire, responses to questions related to work and well-being and organizational culture have also been redacted.</p> <p>A complete list of the variables that have been redacted from the data file is provided in the data file "Summary" tab.</p> <p>Each respondent's record holds a unique identifier in the column named AP_DAT_99.</p> <p>## Data Availability and Accessibility<br> This data set is being made available through Zenodo, an open access repository. There are no restrictions on access to open data except those stated in the copyright and license. Researchers who would like to analyze the full set of unredacted responses are invited to contact the Geneva Learning Foundation to inquire about a Data Sharing Agreement that would stipulate conditions of access (insights@learning.foundation).</p> <p>## Copyright and License<br> © The Geneva Learning Foundation 2022.</p> <p>This data set and all associated files are licensed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0)</p> <p>Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International; https://creativecommons.org/licenses/by-nc-sa/4.0/.</p> <p>Under the terms of this license, you may copy, redistribute and adapt the data set for non-commercial purposes, provided the work is appropriately cited, as indicated above. In any use of this data set, there should be no suggestion that the Foundation endorses any specific organization, products, or services. Any mediation relating to disputes arising under the license shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.</p> <p>General disclaimers. The designations employed and the presentation of the data set do not imply the expression of any opinion whatsoever on the part of the Foundation concerning the legal status of any country, territory, city or area or of its authorities. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the Foundation in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of all reasonable precautions have been taken by the Foundation to verify the information contained in this data set. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for interpretation and use of the material lies with the reader. In no event shall the Foundation be liable for damages arising from its use.</p> <p>The data set contains individual views and does not necessarily represent the decisions or the policies of the Foundation.</p> <p>Version 1.0 (11 August 2023).</p> <p>## References<br> Asiwome Kosi Abiwu, P.H., and Jones, I. (2022). IA2030 Case study 5. Paul Hilarius Asiwome Kosi Abiwu. View from the frontline: building stronger systems (The Geneva Learning Foundation) 10.5281/ZENODO.7004284.</p> <p>Ateke, N.A., and Jones, I. (2022). IA2030 Case study 4. Njoh Andreas Ateke. View from the frontline: working with communities to strengthen immunization programmes (The Geneva Learning Foundation) 10.5281/ZENODO.7004263.</p> <p>Ekwam, D.K., and Jones, I. (2022). IA2030 Case study 13. Pharm. Daniel Kwesi Ekwam. Covering all the bases (The Geneva Learning Foundation) 10.5281/ZENODO.7010227.</p> <p>Faye, W., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Case study 18. Wasnam Faye. Vaccine angels - Give us the opportunity and we can perform miracles. (The Geneva Learning Foundation) 10.5281/ZENODO.7785244.</p> <p>Faye, W., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Étude de cas 18. Wasnam Faye. Les anges de la vaccination : « Donnez-nous l'occasion et nous ferons des miracles. » (The Geneva Learning Foundation) 10.5281/ZENODO.7849329.</p> <p>Ferrah Conteh, Z., and Jones, I. (2022). IA2030 Case study 6. Zainab Ferrah Conteh. View from the frontline: Strenghtening the immunization programme backbone (The Geneva Learning Foundation) 10.5281/ZENODO.7010079.</p> <p>Iwot, N., and Jones, I. (2022). IA2030 Case study 14. Ndaeyo Iwot. Building the capacities of communities (The Geneva Learning Foundation) 10.5281/ZENODO.7010211.</p> <p>Jones, I., Mbuh, C., and Sadki, R. (2023). Listening and Learning at Teach to Reach 7 (IA2030 Listening and Learning Report 4) (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7766585.</p> <p>Jones, I., Mbuh, C., and Sadki, R. (2023). Teach to Reach 7: Partager pour apprendre (Rapport IA2030 «Écouter pour apprendre n° 4) (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7851783.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case study 1. A digital health platform for immunization and primary health care (PHC) engagement (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.6982953.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case study 1. A digital health platform for immunization and primary health care (PHC) engagement (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.6982953.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case Study 10. Development of zero dose situational analyses and action plans (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010177.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case study 2. Squaring the circle: safeguarding existing immunization programmes and primary healthcare during COVID-19 vaccination (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7004191.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case Study 8. Practitioners' perceptions of key immunization challenges (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7005241.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Listening and learning report 1. Working groups consultative engagement through a peer learning platform (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010140.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Movement Year 1 report. Consultative engagement through a digitally enabled peer learning platform (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7119648.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030. Listening and learning report 3. Everyone, everywhere: digital peer learning to leave no one behind (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010209.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). Mouvement pour la vaccination à l'horizon 2030. Rapport Écouter pour apprendre n° 3. Partout, pour tous: l'apprentissage numérique par les pairs pour que personne ne reste sur le côté (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7142102.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., Kovanovic, V., et al. (2022). IA2030 Rapport «Écouter pour apprendre» n° 2. Notre engagement pour la vaccination #VaccinesWork (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7254160.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., Kovanovic, V., et al. (2022). IA2030.Listening and learning report 2. It takes people to make #VaccinesWork (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010196.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Yagnik, A., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., et al. (2022). IA2030 Case Study 9. Understanding and responding to zero-dose challenges (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010171.</p> <p>Jones, I., Watkins, K.E., Sadki, R., Brooks, A., Gasse, F., Yagnik, A., Mbuh, C., Zha, M., Steed, I., Sequeira, J., et al. (2022). IA2030 Case Study 7. Motivation, learning culture and programme performance (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7004304.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V.(2022). IA2030 Year 1 report. Consultative engagement through a digitally enabled peer learning platform (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7119648.</p> <p>Jones, I., Watkins, K.E., Sadki, R., Brooks, A., Gasse, F., Yagnik, A., Mbuh, C., Zha, M., Steed, I., Sequeira, J., et al. (2022). IA2030 Case Study 7. Motivation, learning culture and programme performance (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7004304.</p> <p>Kaboré, B., and Jones, I. (2022). IA2030 Case study 12. Boureima Kaboré. Delivering services in conflict-affected areas (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010188.</p> <p>Kuotong Nongho, R., and Jones, I. (2022). IA2030 Case study 3. Kuotong Nongho Rogers. View from the frontline: microplanning for equity (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7004235.</p> <p>Mbuh, C., Gasse, F., Jones, I., Sadki, R., Brooks, A., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case study 16. Continuum from knowledge to performance (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7014392.</p> <p>Monga, F., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Case study 19. Franck Monga. Building a movement for IA2030 in the Democratic Republic of Congo (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7794726.</p> <p>Monga, F., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Étude de cas 19. Franck Monga. Construire un Mouvement pour la vaccination en République Démocratique du Congo (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7851476.</p> <p>Monzón, M.F., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Case study 17. María Fernanda Monzón. Speaking up for frontline staff (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7785024.</p> <p>Monzón, M.F., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Étude de cas 17. María Fernanda Monzón. Prendre la parole au nom des personnels de première ligne (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7848308.</p> <p>Oketch, P., and Jones, I. (2022). IA2030 Case study 15. Penina Oketch. Planning, people and performance (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010242.</p> <p>Sadki, R., Mbuh, C., Szylovec, A.P., and Brooks, A. (2023). Value creation stories anonymized open data set (Immunization Agenda 2030 Full Learning Cycle, 7 March - 20 June 2022). https://doi.org/10.5281/zenodo.7763922.</p> <p>WHO (2020). Immunization Agenda 2030: A Global Strategy to Leave No One Behind [Internet]. Available from: https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/ia2030. </p> <p>Yagnik, A., Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., et al. (2022). IA2030 Case Study 11. Gender barriers to immunization (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010184.</p>
Investigating vegetation responses to underground nuclear explosions at the Nevada National Security Site through integrated analysis
Data was collected to determine response of vegetation to underground explosions that occurred in the late 1980s. All samples were collected from the vicinity of the BARNWELL and DISKO ELM test sites of the Nevada National Security Site. Samples were collected from 2017-2018. Soil chemistry was derived from plant root simulator (PRS) probes manufactured by Western Ag Innovations Inc., in Saskatoon; tree ring samples were collected from increment borers; vegetation transect information was collected in the field using transects and quadrants and species were also collected and photographs taken for identification at a later time; soil bulk density samples were collected with a metal cylinder of known volume, weighted, oven-dried and re-weighted to obtain both the wet and dry weight; hyperspectral reflectance data were collected form the foliage of piñon pine tree species using a hyperspectral camera (FieldSpec 4, Analytical Spectral Devices, Inc (ASD)). More information on sample collection and processing is available in the manuscript that has been accepted for publication: Solander, K.C., Collins, A.D., Swanson, E., Margolis, E.Q., Crawford, B., Miller, E. Chen, M., Lavadie-Bulnes, A., Ryan, M., Borrego, I., Sevanto, S., Schultz-Fellenz, E., 2021, Investigating vegetation responses to underground nuclear explosions through integrated analysis, J. Geophys. Res. Biogeosci. (accepted).
IA2030 Action Plans and Impact Acceleration Reports: Survey responses from 931 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle 2022)
<p># IA2030 Action Plans and Impact Acceleration Reports: Survey responses from 931 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle 2022)</p> <p>Note: This document includes markdown syntax to facilitate machine reading.</p> <p>## Table of Contents<br> - Abstract<br> - Research Audience<br> - Credits<br> - Recommended Citation<br> - File List<br> - Related Data Sets<br> - Background<br> - Data Set Structure and Contents<br> - Data Cleaning, Data Privacy, and Anonymization<br> - Ethical Considerations<br> - Survey Implementation<br> - Survey Questionnaire Items<br> - Data Availability and Accessibility<br> - Copyright and License<br> - References</p> <p>## Abstract</p> <p>The Immunization Agenda 2030 (IA2030) has been endorsed at the World Health Assembly as the world’s strategy for immunization.</p> <p>The Movement for IA2030 is a voluntary collective of immunization practitioners, principally from low- and middle-income countries, who have pledged to support each other to accelerate local action in support of this global immunization strategy.</p> <p>This data set offers insights into how to understand national and sub-national challenges facing immunization programmes and what strategies show promise for addressing these challenges over time. It contains:<br> - raw, anonymized data in Excel CSV format. Copies of the three survey questionnaires are available for download in the Files section (below).<br> - responses to one, two, or three surveys from 931 national and subnational immunization practitioners participating in the Movement for Immunization Agenda (IA) 2030:</p> <p>Survey 1: IA2030 Action Plan Survey: a 77-item questionnaire, fielded in May 2022, which asked respondents to identify a key challenge relevant to their immunization programme, root cause of the challenge, three corrective actions, and what they knew about vaccination coverage in their zone of intervention.</p> <p>Survey 2: IA2030 Impact Acceleration Report Survey (2022): a 27-item questionnaire, fielded in June 2022, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators.</p> <p>Survey 3: IA2030 Impact Acceleration Report Survey (2023): a 60-item questionnaire, fielded in June 2023, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators.</p> <p>## Research Audience</p> <p>Education and global health researchers with interest in human resources for health (HRH) and the characteristics, priority challenges, and experiences of national and sub-national immunization staff participating in the Movement for Immunization Agenda (IA) 2030.</p> <p>## Credits</p> <p>### Author</p> <p>The Geneva Learning Foundation (TGLF)<br> 18 Avenue Louis Casaï <br> CH1209 Geneva, Switzerland<br> research@learning.foundation</p> <p>Principal Investigator and Corresponding Author<br> Reda Sadki, TGLF<br> reda@learning.foundation</p> <p>Project Partners<br> - Biostat Global Consulting (BGC)<br> - Bridges to Development<br> - Centre for Change & Complexity in Learning (C3L)</p> <p>Partner Roles and Responsibilities<br> - Design: TGLF<br> - Implementation (sample collection): TGLF<br> - Processing: TGLF, C3L<br> - Anonymization: BGC<br> - Submission: TGLF<br> - Maintenance of learning analytics database where data are stored: C3L</p> <p>Funding<br> Wellcome Trust, Bill & Melinda Gates Foundation (BMGF)</p> <p>## Recommended Citation</p> <p>Action Plans and Impact Acceleration Reports: Responses from 931 national and sub-national staff (Immunization Agenda 2030 Full Learning Cycle). The Geneva Learning Foundation, 2023. (Version 1.0) [Data Set]. The Geneval Learning Foundation. https://doi.org/10.5281/zenodo.8298773</p> <p>## File List</p> <p>2023-09.IA2030_Action_Plans_and_Impact_Acceleration_Reports.README.md (this document)</p> <p>2022-05.IA2030_Action_Plan_Survey.docx: List of items included in the Action Plan Survey</p> <p>2022-06.IA2030_Impact_Acceleration_Report_Survey.docx: List of items included in the Impact Acceleration Report Survey questionnaire administered in June 2022.</p> <p>2023-06.IA2030_Impact_Acceleration_Report_Survey.docx: List of additional items included in the Impact Acceleration Survey administered in June 2023 (the complete survey questionnaire also included all items included in the June 2022 Impact Acceleration Report Survey questionnaire).</p> <p>2023-09.IA2030_Action_Plans_and_Impact_Acceleration_Reports_Survey_Dataset.csv: Anonymized Action Plans and Acceleration Reports Survey Dataset. Version 1: Geneva Learning Foundation (937 observations, 173 variables).</p> <p>## Related Data Sets</p> <p>The 2023-09.IA2030_Action_Plans_and_Impact Acceleration_Reports_Survey_Dataset.csv is a subset of data collected by The Geneva Learning Foundation (TGLF) during the first IA2030 Full Learning Cycle (FLC) during May 2022, June 2022, and June 2023. The complete IA 2030 Action Plans and Impact Acceleration Reports Survey data set is more comprehensive and includes information about respondent and programme characteristics as well as responses to open-text questions. </p> <p>Researchers who would like to analyze the full set of unredacted responses are invited to contact the Geneva Learning Foundation to inquire about a data sharing agreement that would stipulate conditions of access (insights@learning.foundation).</p> <p>The Geneva Learning Foundation, 2023. Value Creation Stories (VCS) weekly feedback survey, 2022 Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) (Version 1.0). [Data Set]. The Geneva Learning Foundation. https://doi.org/10.5281/zenodo.7763922 </p> <p>The Geneva Learning Foundation, 2023. Full Learning Cycle (2022) Application for national and sub-national immunization staff to identify challenges and join the Movement for Immunization Agenda (IA 2030) (Version 1.0) [Data Set]. The Geneval Learning Foundation. https://doi.org/10.5281/zenodo.8199552</p> <p>Additional data sets for the first Full Learning Cycle (FLC) of the Movement for Immunization Agenda 2030 (IA2030) are available from TGLF’s Insights Unit (insights@learning.foundation).</p> <p>## Background</p> <p>The Immunization Agenda 2030 (IA2030), the global immunization strategy for 2021-2030, set ambitious targets for global immunization coverage and other key indicators (World Health Organization [WHO], 2020).</p> <p>In response to the WHO Director-General’s call for a social movement to ensure immunization remains a priority for global and regional health agendas and promote broad societal support for immunization (WHO, 2020), TGLF, working with its global community of over 35,000 alumni, developed a learning programme intended to contribute to a “Movement for Immunization Agenda 2030.” As part of their participation in the programme, IA2030 participants developed a locally tailored action plan designed to address a key challenge relevant to their immunization programme. A project kick-off phase, the “Impact Accelerator Launch Pad”, supported participants during their initial implementation stages, to create momentum for sustained action. One month after initiation of their Action Plan(s), participants were invited to complete an Impact Acceleration survey questionnaire to assess progress towards their goals. One year later, programme participants were invited to complete a second Impact Acceleration questionnaire to assess continued progress towards their goal.</p> <p>This data set includes participants’ responses to one or more questionnaires documenting their IA2030 experience:<br> - Survey 1: IA2030 Action Plan Survey: a 77-item questionnaire, fielded in May 2022, which asked respondents to identify a key challenge relevant to their immunization programme, root cause of the challenge, three corrective actions, and what they knew about vaccination coverage in their zone of intervention.<br> - Survey 2: IA2030 Impact Acceleration Report Survey (2022): a 27-item questionnaire, fielded in June 2022, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators.<br> - Survey 3: IA2030 Impact Acceleration Report Survey (2023): a 60-item questionnaire, fielded in June 2023, which asked respondents to report progress on implementation of their IA2030 Action Plan, including progress on vaccination coverage indicators.</p> <p>## Data Set Structure and Contents</p> <p>The data set has 937 observations and 173 variables. Contents include the following:<br> - 937 responses (532 English; 405 French) to the Action Plan Survey. Six individuals submitted two distinct Action Plans.<br> - 538 responses (278 English; 260 French) to the 2022 Impact Acceleration Report Survey<br> - 236 responses (126 English; 110 French) to the 2023 Impact Acceleration Report Survey<br> - Column A describes the type of data included in each row of the data file<br> - The first two rows of the data set hold the question text in English and in French<br> - Column B contains a unique identifier for each respondent. The ID is a simple string starting with a number to indicate a unique person and then a dash, and then a 1 or a 2 to indicate whether it is their first or second entry for the 2022 Impact Acceleration Report Survey. <br> - Columns D-F indicate the language each respondent used for each of the three questionnaires (EN = English; FR = French)<br> - The columns whose names start with I1 were collected as part of the Action Plan Survey, I2 as part of the 2022 Impact Acceleration Report Survey, and I3 as part of the 2023 Impact Acceleration Report Survey. The columns appear in left-to-right order in which the original surveys were administered.</p> <p>## Data Cleaning, Data Privacy, and Anonymization</p> <p>Duplicate surveys submitted by the same individual were removed from the data set. When a respondent submitted multiple versions of the Action Plan or 2023 Impact Acceleration Report Survey, the submission with the most complete responses was retained. Six persons submitted two distinct records for the 2022 Impact Acceleration Report Survey. In those cases, both responses appear in the dataset, paired with that person’s single retained entry for the Action Plan and their single retained entry for the 2023 Impact Acceleration Report Survey (where applicable).</p> <p>The data file shared on this site is intentionally incomplete. Columns containing holding personally identifying information (e.g., respondent email address, date of birth, WhatsApp number, organization name, country) and columns potentially holding personally identifying information (e.g., responses to items such as “summarize your challenge,” “tell us about your stakeholders”) have been replaced with the following phrases:</p> <p>- “Removed to protect personally identifying information” (English questionnaires)<br> - “Supprimé pour protéger les informations personnelles” (French questionnaires)</p> <p>## Ethical Considerations </p> <p>Ethical clearance for each of the three surveys was granted by TGLF prior to its administration. Privacy was safeguarded by data management complying with the [General Data Protection Regulation](https://gdpr-info.eu/). All participants were informed that participation was voluntary and were assured their data would be confidential. Participants provided consent prior to completing each survey. Respondents did not receive any incentive for participating in any of the surveys.</p> <p>All information collected for the three surveys was secured with multiple levels of encryption and access controls to guarantee participant confidentiality, per [Typeform policy](https://www.typeform.com/help/a/security-at-typeform-360029259552/)).</p> <p>## Survey Implementation</p> <p>For each of the three surveys, IA2030 participants received an email message inviting them to complete a questionnaire. Respondents accessed the questionnaire by clicking a link contained in the email.</p> <p>All surveys were hosted on the Typeform server and followed the same methods for protecting respondent privacy (details provided in Ethical Considerations section, above). Respondents were given the choice of completing each questionnaire in either English or French.</p> <p>All survey questionnaires included a mixture of multiple-choice and open-text items. Overviews of the contents of each survey are provided in the next three subsections. Copies of the survey instruments are available for download in the Files section (below).</p> <p>## Survey Questionnaire Items</p> <p>### IA 2030 Action Plan Survey Items</p> <p>- To start your IA2030 Action Plan, describe one challenge you face in your immunization work. We suggest you focus on your most difficult and important challenge. Focus on only one problem where you can take action. Be specific about your situation, not generalities. Help others understand why it matters. Explain your situation. What is the root cause of your challenge? What will be different if you overcome this challenge?<br> - Summarize your challenge and what you want to do about it.<br> - Is your challenge too broad, general, or vague, like “coverage is too low” or “there are unvaccinated children”? Can you take action at your level to tackle this challenge?<br> - Immunization Agenda 2030 is organized into seven Strategic Priorities (SP). Review the list carefully to select the Strategic Priority that best fits your challenge. IA2030 Strategic Priorities are organized into 47 Key Focus Areas (KFAs). Review the list carefully to select the item that best fits your challenge.<br> - Is your challenge related to any of these?<br> - To tackle your challenge, define the goal of your IA2030 Action Plan.<br> - Why is this goal important? Answer the question, “If I achieve my goal, what will be different?” What does success look like?<br> - Have you started to take action toward this goal?<br> - Summarize what you have already done toward this goal. Who did what, when and how? How did it turn out? Do you have any concrete results to date? What are the lessons or surprises so far?<br> - Tell us about your stakeholders. Who will you need to work with to achieve your goal? What type of support will you need from the communities you serve? How should your organization, supervisor, and partners support you? What are the likely barriers to securing their support and commitment? What are you going to do if a stakeholder does not provide the support you need? Could the support of IA2030 Movement colleagues be helpful to you and, if so, how?<br> - Do you need additional funding to achieve your goal?<br> - How much time do you need to achieve your goal? (Less than one month, 1-3 months. 4-6 months, 7-12 months, 13-18 months, 19-24 month, more than 24 months)<br> - Tell us more about resources and timeline. Provide a rough initial estimate of the time and budget required for your Action Plan. If this is premature, indicate what you need to know to be able to determine time and budget required.<br> - What resources (time, people, money) will you need to achieve your goal? How are you going to secure these resources? Summarize the steps to secure resources.<br> - Now, we would like you to identify three different, specific actions to achieve the goal of your IA2030 Action Plan: Action 1. What do you want to do? Have you done this before? Who will carry out this action? How much time do you need to finish this action? How innovative is this action? Tell us more about this action?<br> - Explain why this action matters. How will this action help you achieve your goal? What needs to happen and when? What are the steps to finish this action? Who will carry out this action? How will you know when you have finished your action? How will you know if your action is successful?<br> - What else needs to happen to achieve your goal?<br> - What other actions need to be taken? When do they need to happen? Who will carry them out? How will these actions help to achieve your goal? What is your role in them? What control do you have over these actions?<br> - Do you wish to share experience to help you with your IA2030 Action Plan and to help others?<br> - What is the name of your organizational unit or area of intervention?<br> - What is the main type of environment in: [your zone of intervention]?<br> - Do you know the size of the vaccination target population in: [your zone of intervention]?<br> - What is the size of the population in: [your zone of intervention]?<br> - Do you know the number of outreach immunization sessions that were planned and then actually carried out last year:<br> - What was the number of planned outreach immunization sessions held last year in: [your zone of intervention]?<br> - What was the number of outreach immunization sessions that were actually carried out last year in: [your zone of intervention]?<br> - Do you know the Antenatal Care (ANC) Coverage in: [your zone of intervention]?<br> - What is the Antenatal Care (ANC) Coverage in: [your zone of intervention]?<br> - Do you know the current Penta 1 coverage in: [your zone of intervention]?<br> - What is the current Penta 1 coverage in: [your zone of intervention]?<br> - Do you know the current Penta 3 coverage in: [your zone of intervention]?<br> - What is the current Penta 3 coverage in: [your zone of intervention]?<br> - Do you know the MCV1 immunization coverage in: [your zone of intervention]?<br> - What is the MCV1 immunization coverage in: [your zone of intervention]?<br> - Do you know the MCV2 immunization coverage in: [your zone of intervention]?<br> - What is the MCV2 immunization coverage in: [your zone of intervention]?<br> - Do you know the vaccination coverage for the first dose of COVID-19 vaccine in: [your zone of intervention]?<br> - What is the vaccination coverage for the first dose of COVID-19 vaccine in your area?<br> - You have now prepared your IA2030 Action Plan. Are you ready to take action? If your Action Plan is accepted, you will be invited to join the 2nd IA2030 Impact Accelerator Launch Pad to work with others during four weeks to start implementing your Action Plan.<br> - What will you seek to achieve in the FOUR WEEKS of the Launch Pad?<br> - What is the MOST IMPORTANT ACTION that you will carry out in the first 7 days of joining the Launch Pad?</p> <p>### IA2030 Impact Acceleration Report Survey Items (2022)</p> <p>- Has there been a CHANGE or PROGRESS since your last Acceleration Report? Tell us what has happened. -What has changed since your last Acceleration Report?<br> - What is the implementation status of your action plan?<br> - (If applicable) Please tell us why you have not yet started to implement your IA2030 action plan. What are the barriers or obstacles that have prevented you from starting implementation? What support do you need that will help you overcome these barriers? What will you do now to start implementing?<br> - Tell us more about the implementation status of your action plan. What actions did you take and what changed as a result of your actions? What are the results? What were the challenges and how did you address them? What strategies or solutions were critical to implementation? Who or what helped you? What lessons did you learn? Was there anything that surprised you? Is there anything else you would like us to know?<br> - Is your action plan integrated with the broader EPI programme?<br> - Has participation in your Scholar Country Team’s activities been USEFUL to you?<br> - Have you interacted personally with other members of the IA2030 Movement since your last Acceleration Report?? (If yes) What was the main reason for this interaction?<br> - How many Movement members have you personally interacted with since your last Acceleration Report?<br> - Name up to three Movement members that you have personally interacted with since your last Acceleration Report.<br> - Do you have something you would like to share about implementation of your IA2030 action plan? (If yes) Please tell us what happened and how it turned out. Why does this matter? How did you identify it? What have you done to learn more about it? What strategies or solutions have you tried or would you consider? Who or what can help you? What lessons have you learned so far? Was there anything that surprised you? Anything else that we need to know?<br> - Did you participate in the IA2030 Impact Accelerator Launch Pad from 23 May - 17 June 2022?<br> - Has your participation in the Accelerator helped you progress toward implementation of your IA2030 action plan? Tell us how the Accelerator has helped (or not) you progress toward implementation of your IA2030 action plan.<br> - What was the most valuable aspect of the Accelerator for you?<br> - Would you participate in the next IA2030 Impact Accelerator Launch Pad?<br> - Any other comments or feedback?</p> <p>### IA2030 Impact Acceleration Report Survey Items (2023)</p> <p>*Same questions as for Accelerator Report 2022, with the addition of the<br> following:*</p> <p>- How many HOURS PER WEEK on the average did you EXPECT TO SPEND to implement your plan?<br> - How many HOURS PER WEEK on the average did you ACTUALLY DEDICATE to implement your plan?<br> - What percentage of your work time have you spent on implementation of this action plan?<br> - Did someone provide funding towards the implementation of your action plan? (specify)<br> - Estimate the total budget in U.S. dollars (USD or US$) you need to implement your action plan. You will then be asked to justify this budget.<br> - If you have not yet developed a budget for your action plan, a rough estimate will suffice. Enter this amount in U.S. dollars.<br> - Do you need additional financial resources to successfully implement your action plan?<br> - Of this total budget US$ ,how much are you currently short, in U.S. dollars?<br> - Do you know where to get this additional funding for your action plan?<br> - Justify your estimate of this budget (US$ ) and the need for additional resources (if any).<br> - Summarize what these resources would be used for. Without these resources, what will happen?<br> - If your action plan is successful, how many more people will be vaccinated?<br> - If your action plan is successful, what will be different for the target population?<br> - In the last year, has there been a significant change in vaccination coverage indicators?<br> - This change is the result of my involvement in the IA2030 Movement (range: 1=Strongly disagree to 6=Strongly agree)<br> - To what do you primarily attribute this change?<br> - Explain why you primarily attribute this change to [factor]<br> - Without [factor] what would have been different? Why? How did your involvement in the IA2030 Movement contribute to this change?</p> <p>## Data Availability and Accessibility</p> <p>This data set is being made available through Zenodo, an open access repository. There are no restrictions on access to open data except those stated in the copyright and license. Researchers who would like to analyze the full set of unredacted responses are invited to contact the Geneva Learning Foundation to inquire about a data sharing agreement that would stipulate conditions of access (<insights@learning.foundation>).</p> <p>## Copyright and License</p> <p>© The Geneva Learning Foundation 2023.</p> <p>This data set and all associated files are licensed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0)</p> <p>Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International; https://creativecommons.org/licenses/by-nc-sa/4.0/.</p> <p>Under the terms of this license, you may copy, redistribute and adapt the data set for non-commercial purposes, provided the work is appropriately cited, as indicated above. In any use of this data set, there should be no suggestion that the Foundation endorses any specific organization, products, or services. Any mediation relating to disputes arising under the license shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.</p> <p>### General disclaimers</p> <p>The designations employed and the presentation of the data set do not imply the expression of any opinion whatsoever on the part of the Foundation concerning the legal status of any country, territory, city or area or of its authorities. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the Foundation in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of all reasonable precautions have been taken by the Foundation to verify the information contained in this data set. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for interpretation and use of the material lies with the reader. In no event shall the Foundation be liable for damages arising from its use.</p> <p>The data set contains individual views and does not necessarily represent the decisions or the policies of the Foundation.</p> <p>Version 1.0 (September 2023).</p> <p>## References</p> <p>Asiwome Kosi Abiwu, P.H., and Jones, I. (2022). IA2030 Case study 5. Paul Hilarius Asiwome Kosi Abiwu. View from the frontline: building stronger systems (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo7004284.</p> <p>Ateke, N.A., and Jones, I. (2022). IA2030 Case study 4. Njoh Andreas Ateke. View from the frontline: working with communities to strengthen immunization programmes (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo7004263.</p> <p>Ekwam, D.K., and Jones, I. (2022). IA2030 Case study 13. Pharm. Daniel Kwesi Ekwam. Covering all the bases (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo7010227.</p> <p>Faye, W., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Case study 18. Wasnam Faye. Vaccine angels - Give us the opportunity and we can perform miracles. (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo7785244.</p> <p>Faye, W., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Étude de cas 18. Wasnam Faye. Les anges de la vaccination: « Donnez-nous l’occasion et nous ferons des miracles. » (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7849329.</p> <p>Ferrah Conteh, Z., and Jones, I. (2022). IA2030 Case study 6. Zainab Ferrah Conteh. View from the frontline: Strenghtening the immunization programme backbone (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010079.</p> <p>Iwot, N., and Jones, I. (2022). IA2030 Case study 14. Ndaeyo Iwot. Building the capacities of communities (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010211.</p> <p>Jones, I., Mbuh, C., and Sadki, R. (2023). Listening and Learning at Teach to Reach 7 (IA2030 Listening and Learning Report 4) (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7766585.</p> <p>Jones, I., Mbuh, C., and Sadki, R. (2023). Teach to Reach 7: Partager pour apprendre (Rapport IA2030 «Écouter pour apprendre n° 4) (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7851783.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case study 1. A digital health platform for immunization and primary health care (PHC) engagement (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.6982953.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case study 1. A digital health platform for immunization and primary health care (PHC) engagement (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.6982953.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case Study 10. Development of zero dose situational analyses and action plans (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010177.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case study 2. Squaring the circle: safeguarding existing immunization programmes and primary healthcare during COVID-19 vaccination (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7004191.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case Study 8. Practitioners’ perceptions of key immunization challenges (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7005241.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Listening and learning report 1. Working groups consultative engagement through a peer learning platform (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010140.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Movement Year 1 report. Consultative engagement through a digitally enabled peer learning platform (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7119648.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030. Listening and learning report 3. Everyone, everywhere: digital peer learning to leave no one behind (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010209.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). Mouvement pour la vaccination à l’horizon 2030. Rapport Écouter pour apprendre n° 3. Partout, pour tous: l’apprentissage numérique par les pairs pour que personne ne reste sur le côté (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7142102.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., Kovanovic, V., et al. (2022). IA2030 Rapport «Écouter pour apprendre» n° 2. Notre engagement pour la vaccination #VaccinesWork (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7254160.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., Kovanovic, V., et al. (2022). IA2030.Listening and learning report 2. It takes people to make #VaccinesWork (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010196.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Yagnik, A., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., et al. (2022). IA2030 Case Study 9. Understanding and responding to zero-dose challenges (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010171.</p> <p>Jones, I., Watkins, K.E., Sadki, R., Brooks, A., Gasse, F., Yagnik, A., Mbuh, C., Zha, M., Steed, I., Sequeira, J., et al. (2022). IA2030 Case Study 7. Motivation, learning culture and programme performance (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7004304.</p> <p>Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V.(2022). IA2030 Year 1 report. Consultative engagement through a digitally enabled peer learning platform (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7119648.</p> <p>Jones, I., Watkins, K.E., Sadki, R., Brooks, A., Gasse, F., Yagnik, A., Mbuh, C., Zha, M., Steed, I., Sequeira, J., et al. (2022). IA2030 Case Study 7. Motivation, learning culture and programme performance (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7004304.</p> <p>Kaboré, B., and Jones, I. (2022). IA2030 Case study 12. Boureima Kaboré. Delivering services in conflict-affected areas (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010188.</p> <p>Kuotong Nongho, R., and Jones, I. (2022). IA2030 Case study 3. Kuotong Nongho Rogers. View from the frontline: microplanning for equity (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7004235.</p> <p>Mbuh, C., Gasse, F., Jones, I., Sadki, R., Brooks, A., Zha, M., Steed, I., Sequeira, J., Churchill, S., and Kovanovic, V. (2022). IA2030 Case study 16. Continuum from knowledge to performance (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7014392.</p> <p>Monga, F., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Case study 19. Franck Monga. Building a movement for IA2030 in the Democratic Republic of Congo (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7794726.</p> <p>Monga, F., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Étude de cas 19. Franck Monga. Construire un Mouvement pour la vaccination en République Démocratique du Congo (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7851476.</p> <p>Monzón, M.F., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Case study 17. María Fernanda Monzón. Speaking up for frontline staff (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7785024.</p> <p>Monzón, M.F., Jones, I., Mbuh, C., and Sadki, R. (2023). IA2030 Étude de cas 17. María Fernanda Monzón. Prendre la parole au nom des personnels de première ligne (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7848308.</p> <p>Oketch, P., and Jones, I. (2022). IA2030 Case study 15. Penina Oketch. Planning, people and performance (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010242.</p> <p>Sadki, R., Mbuh, C., Szylovec, A.P., and Brooks, A. (2023). Value creation stories anonymized open data set (Immunization Agenda 2030 Full Learning Cycle, 7 March - 20 June 2022). https://doi.org/10.5281/zenodo.7763922.</p> <p>Sadki, R. Mbuh, C., Zha, M., Gasse, F., Brooks, A. The Geneva Learning Foundation, 2023. Full Learning Cycle (2022) Application for national and sub-national immunization staff to identify challenges and join the Movement for Immunization Agenda (IA 2030) (Version 1.0) [Data Set]. The Geneval Learning Foundation.https://doi.org/10.5281/zenodo.8199552</p> <p>Umbelino-Walker, I., Szylovec, A.P., Brooks, A., Sadki, R., Mbuh, C., Jones, I., Monglo, A., Dakan, B.A. (2023). Towards a sustainable model for a digital learning network in support of the Immunization Agenda 2030 -- a mixed methods study with a transdisciplinary component. Manuscript under review.</p> <p>WHO (2020). Immunization Agenda 2030: A Global Strategy to Leave No One Behind [Internet]. Available from: https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/ia2030. </p> <p>Yagnik, A., Jones, I., Sadki, R., Brooks, A., Gasse, F., Mbuh, C., Zha, M., Steed, I., Sequeira, J., Churchill, S., et al. (2022). IA2030 Case Study 11. Gender barriers to immunization (The Geneva Learning Foundation) https://doi.org/10.5281/zenodo.7010184.</p>
Use of Animations Movies to Increase Response in a National Health Survey
ClinicalTrials.gov study NCT05520242. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.